Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$22.88 - $35.28 $18,189 - $28,047
-795 Reduced 80.06%
198 $5,000
Q1 2022

May 16, 2022

BUY
$28.1 - $35.25 $15,483 - $19,422
551 Added 124.66%
993 $32,000
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $2,165 - $3,212
73 Added 19.78%
442 $15,000
Q3 2021

Nov 16, 2021

BUY
$43.09 - $82.26 $1,680 - $3,208
39 Added 11.82%
369 $16,000
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $104 - $137
2 Added 0.61%
330 $22,000
Q1 2021

May 17, 2021

BUY
$43.96 - $55.99 $12,660 - $16,125
288 Added 720.0%
328 $17,000
Q4 2020

Feb 16, 2021

BUY
$27.19 - $44.68 $543 - $893
20 Added 100.0%
40 $2,000
Q3 2020

Nov 17, 2020

BUY
$27.01 - $37.31 $540 - $746
20 New
20 $1,000
Q3 2018

Nov 15, 2018

SELL
$189.1 - $282.92 $378 - $565
-2 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$123.8 - $192.48 $247 - $384
2 New
2 $0

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $218M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.